• Staying Between the Lines: Why Time in Range Matters

    Information provided by Dexcom

    The use of continuous glucose monitoring (CGM) has created new glucose metrics for both people with diabetes and healthcare professionals to incorporate into diabetes management. While A1C is an average, time in range (TIR) captures when glucose is in the target range (70-180 mg/dL for most individuals), as well as when glucose is above range and below range, providing critical information for treatment decisions and health behavior changes. Time in range discussions can lead to more productive diabetes conversations when incorporating strength-based language principles and can lead to discovery learning.

    Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, is an Endocrine Clinical Pharmacy Specialist, and the CGM and Remote Monitoring Program Coordinator, at Cleveland Clinic Endocrinology & Metabolism Institute. As a CGM expert, she frequently educates people on the benefits of incorporating CGM into practice and the International Consensus Guidelines on time in range.1

    This video presentation will highlight the guidelines on TIR, as well as the advantages of incorporating TIR and other CGM metrics when managing diabetes.

    The key topics include:

    • International Consensus Guidelines for TIR
    • Challenges of A1C when managing diabetes
    • Glycemic variability
    • Association of TIR and diabetes complications
    • Opportunities to help people with diabetes increase TIR
    • Application of TIR and other CGM metrics to two case studies

    Watch this video to learn how you can incorporate TIR into your diabetes management discussions with people living with diabetes.

    Learn more about The Global Movement for Time in Range and find additional resources at www.wheninrange.com .

    Reference

    1. Battelino T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603.

    Disclaimer

    The posting of sponsored information and content on this page should not be considered an AAFP endorsement or recommendation of the sponsor's products, services, policies, or procedures. The information and opinions expressed on this page are those of the paid sponsors and do not necessarily reflect the view of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page; moreover, any links on this page to third-party websites where goods or services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods, or services.